cbdMD, Inc. (YCBD) Tops Q4 EPS by 27c

cbdMD, Inc. (NYSE: YCBD) reported Q4 EPS of ($0.08), $0.27 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $11.5 million.

For earnings history and earnings-related data on cbdMD, Inc. (YCBD) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• UBS Downgrades Core Natural Resources (CNR) to Neutral
• Mercury Systems (MRCY) Misses Q4 EPS by 2c